P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET-adapted era. A single center retrospective study.

• Andrea Visentin,
• Alessandro Cellini,
• Chiara Adele Cavarretta,
• Leila Romano Gargarella,
• Francesco Angotzi,
• Valeria Ruocco,
• Simone Zoletto,
• Stefano Pravato,
• Marco Pizzi,
• Federica Vianello,
• Filippo Crimì,
• Stefania Vio,
• Michele Gregianin,
• Livio Trentin

Affiliations

Andrea Visentin

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova

Alessandro Cellini

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova

Chiara Adele Cavarretta

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova

Leila Romano Gargarella

2 Hematology and Bone Marrow unit, Hospital L’angelo, Mestre

Francesco Angotzi

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova

Valeria Ruocco

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova

Simone Zoletto

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova

Stefano Pravato

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova

Marco Pizzi

3 General Pathology & Cytopathology Unit, Department of Medicine, University of Padova

Federica Vianello

4 Radiotherapy Unit, Veneto Institute of Oncology IOV-IRCCS, Padova

Filippo Crimì

5 Radiology Institute, Department of Medicine, University of Padova,

Stefania Vio

6 Radiology unit, Azienda Ospedale Università Padova

Michele Gregianin

7 Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCCS, Castelfranco Veneto

Livio Trentin

1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova